Abstract
Summary
LPI (LP Information)' newest research report, the “Cell Regeneration Medicine Industry Forecast” looks at past sales and reviews total world Cell Regeneration Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Regeneration Medicine sales for 2023 through 2029. With Cell Regeneration Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Regeneration Medicine industry.
This Insight Report provides a comprehensive analysis of the global Cell Regeneration Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Regeneration Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Regeneration Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Regeneration Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Regeneration Medicine.
The global Cell Regeneration Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Regeneration Medicine players cover Abbott, Amgen Inc., Astellas Pharma, Inc., AstraZeneca plc, Baxter International, Inc., Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb and Corline Biomedical AB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Regeneration Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Primary Cell-based Therapeutics
Stem Cell & Progenitor Cell-based Therapeutics
Cell-based Immunotherapies
Gene Therapies
Segmentation by application
Dermatology
Musculoskeletal
Immunology and Inflammation
Oncology
Cardiovascular
Ophthalmology
Other Therapeutic Categories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Amgen Inc.
Astellas Pharma, Inc.
AstraZeneca plc
Baxter International, Inc.
Bayer AG
Boehringer Ingelheim
Bristol-Myers Squibb
Corline Biomedical AB
This Insight Report provides a comprehensive analysis of the global Cell Regeneration Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Regeneration Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Regeneration Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Regeneration Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Regeneration Medicine.
The global Cell Regeneration Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Regeneration Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Regeneration Medicine players cover Abbott, Amgen Inc., Astellas Pharma, Inc., AstraZeneca plc, Baxter International, Inc., Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb and Corline Biomedical AB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Regeneration Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Primary Cell-based Therapeutics
Stem Cell & Progenitor Cell-based Therapeutics
Cell-based Immunotherapies
Gene Therapies
Segmentation by application
Dermatology
Musculoskeletal
Immunology and Inflammation
Oncology
Cardiovascular
Ophthalmology
Other Therapeutic Categories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Amgen Inc.
Astellas Pharma, Inc.
AstraZeneca plc
Baxter International, Inc.
Bayer AG
Boehringer Ingelheim
Bristol-Myers Squibb
Corline Biomedical AB
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Regeneration Medicine Market Size 2018-2029
2.1.2 Cell Regeneration Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell Regeneration Medicine Segment by Type
2.2.1 Primary Cell-based Therapeutics
2.2.2 Stem Cell & Progenitor Cell-based Therapeutics
2.2.3 Cell-based Immunotherapies
2.2.4 Gene Therapies
2.3 Cell Regeneration Medicine Market Size by Type
2.3.1 Cell Regeneration Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell Regeneration Medicine Market Size Market Share by Type (2018-2023)
2.4 Cell Regeneration Medicine Segment by Application
2.4.1 Dermatology
2.4.2 Musculoskeletal
2.4.3 Immunology and Inflammation
2.4.4 Oncology
2.4.5 Cardiovascular
2.4.6 Ophthalmology
2.4.7 Other Therapeutic Categories
2.5 Cell Regeneration Medicine Market Size by Application
2.5.1 Cell Regeneration Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell Regeneration Medicine Market Size Market Share by Application (2018-2023)
3 Cell Regeneration Medicine Market Size by Player
3.1 Cell Regeneration Medicine Market Size Market Share by Players
3.1.1 Global Cell Regeneration Medicine Revenue by Players (2018-2023)
3.1.2 Global Cell Regeneration Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Cell Regeneration Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Regeneration Medicine by Regions
4.1 Cell Regeneration Medicine Market Size by Regions (2018-2023)
4.2 Americas Cell Regeneration Medicine Market Size Growth (2018-2023)
4.3 APAC Cell Regeneration Medicine Market Size Growth (2018-2023)
4.4 Europe Cell Regeneration Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell Regeneration Medicine Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cell Regeneration Medicine Market Size by Country (2018-2023)
5.2 Americas Cell Regeneration Medicine Market Size by Type (2018-2023)
5.3 Americas Cell Regeneration Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Regeneration Medicine Market Size by Region (2018-2023)
6.2 APAC Cell Regeneration Medicine Market Size by Type (2018-2023)
6.3 APAC Cell Regeneration Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Regeneration Medicine by Country (2018-2023)
7.2 Europe Cell Regeneration Medicine Market Size by Type (2018-2023)
7.3 Europe Cell Regeneration Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Regeneration Medicine by Region (2018-2023)
8.2 Middle East & Africa Cell Regeneration Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell Regeneration Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell Regeneration Medicine Market Forecast
10.1 Global Cell Regeneration Medicine Forecast by Regions (2024-2029)
10.1.1 Global Cell Regeneration Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Cell Regeneration Medicine Forecast
10.1.3 APAC Cell Regeneration Medicine Forecast
10.1.4 Europe Cell Regeneration Medicine Forecast
10.1.5 Middle East & Africa Cell Regeneration Medicine Forecast
10.2 Americas Cell Regeneration Medicine Forecast by Country (2024-2029)
10.2.1 United States Cell Regeneration Medicine Market Forecast
10.2.2 Canada Cell Regeneration Medicine Market Forecast
10.2.3 Mexico Cell Regeneration Medicine Market Forecast
10.2.4 Brazil Cell Regeneration Medicine Market Forecast
10.3 APAC Cell Regeneration Medicine Forecast by Region (2024-2029)
10.3.1 China Cell Regeneration Medicine Market Forecast
10.3.2 Japan Cell Regeneration Medicine Market Forecast
10.3.3 Korea Cell Regeneration Medicine Market Forecast
10.3.4 Southeast Asia Cell Regeneration Medicine Market Forecast
10.3.5 India Cell Regeneration Medicine Market Forecast
10.3.6 Australia Cell Regeneration Medicine Market Forecast
10.4 Europe Cell Regeneration Medicine Forecast by Country (2024-2029)
10.4.1 Germany Cell Regeneration Medicine Market Forecast
10.4.2 France Cell Regeneration Medicine Market Forecast
10.4.3 UK Cell Regeneration Medicine Market Forecast
10.4.4 Italy Cell Regeneration Medicine Market Forecast
10.4.5 Russia Cell Regeneration Medicine Market Forecast
10.5 Middle East & Africa Cell Regeneration Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Cell Regeneration Medicine Market Forecast
10.5.2 South Africa Cell Regeneration Medicine Market Forecast
10.5.3 Israel Cell Regeneration Medicine Market Forecast
10.5.4 Turkey Cell Regeneration Medicine Market Forecast
10.5.5 GCC Countries Cell Regeneration Medicine Market Forecast
10.6 Global Cell Regeneration Medicine Forecast by Type (2024-2029)
10.7 Global Cell Regeneration Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Cell Regeneration Medicine Product Offered
11.1.3 Abbott Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Information
11.2.2 Amgen Inc. Cell Regeneration Medicine Product Offered
11.2.3 Amgen Inc. Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Amgen Inc. Main Business Overview
11.2.5 Amgen Inc. Latest Developments
11.3 Astellas Pharma, Inc.
11.3.1 Astellas Pharma, Inc. Company Information
11.3.2 Astellas Pharma, Inc. Cell Regeneration Medicine Product Offered
11.3.3 Astellas Pharma, Inc. Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Astellas Pharma, Inc. Main Business Overview
11.3.5 Astellas Pharma, Inc. Latest Developments
11.4 AstraZeneca plc
11.4.1 AstraZeneca plc Company Information
11.4.2 AstraZeneca plc Cell Regeneration Medicine Product Offered
11.4.3 AstraZeneca plc Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AstraZeneca plc Main Business Overview
11.4.5 AstraZeneca plc Latest Developments
11.5 Baxter International, Inc.
11.5.1 Baxter International, Inc. Company Information
11.5.2 Baxter International, Inc. Cell Regeneration Medicine Product Offered
11.5.3 Baxter International, Inc. Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Baxter International, Inc. Main Business Overview
11.5.5 Baxter International, Inc. Latest Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Information
11.6.2 Bayer AG Cell Regeneration Medicine Product Offered
11.6.3 Bayer AG Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bayer AG Main Business Overview
11.6.5 Bayer AG Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Cell Regeneration Medicine Product Offered
11.7.3 Boehringer Ingelheim Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Cell Regeneration Medicine Product Offered
11.8.3 Bristol-Myers Squibb Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 Corline Biomedical AB
11.9.1 Corline Biomedical AB Company Information
11.9.2 Corline Biomedical AB Cell Regeneration Medicine Product Offered
11.9.3 Corline Biomedical AB Cell Regeneration Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Corline Biomedical AB Main Business Overview
11.9.5 Corline Biomedical AB Latest Developments
12 Research Findings and Conclusion